The issues were focused in two of its product categories: cardiac assist and cardiopulmonary. In June, the company predicted possible breaches of sterile packaging could negatively affect its ” sales, mix and earnings for the rest of the year.”
During the second quarter, net sales increased 1.3 percent during the quarter, but the number of orders fell 4.5 percent.
